Aurinia Pharmaceuticals
AUPH
#4836
Rank
โ‚ฌ1.68 B
Marketcap
13,13ย โ‚ฌ
Share price
-3.54%
Change (1 day)
82.00%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): โ‚ฌ0.11 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.29 Billion. In 2025 the company made an earning of โ‚ฌ0.10 Billion, an increase over its 2024 earnings that were of โ‚ฌ10.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.11 B15.92%
2025 โ‚ฌ0.10 B864.64%
2024 โ‚ฌ10.55 M-116.44%
2023 -โ‚ฌ64.18 Million-31.8%
2022 -โ‚ฌ94.11 Million-39.4%
2021 -โ‚ฌ0.16 Billion61.9%
2020 -โ‚ฌ95.92 Million-9.73%
2019 -โ‚ฌ0.11 Billion92.65%
2018 -โ‚ฌ55.16 Million36.39%
2017 -โ‚ฌ40.44 Million106.29%
2016 -โ‚ฌ19.61 Million-15.4%
2015 -โ‚ฌ23.17 Million65.84%
2014 -โ‚ฌ13.98 Million129.82%
2013 -โ‚ฌ6.08 Million-26.6%
2012 -โ‚ฌ8.29 Million
2010 -โ‚ฌ4.69 Million-39.22%
2009 -โ‚ฌ7.72 Million-43.78%
2008 -โ‚ฌ13.73 Million-53.19%
2007 -โ‚ฌ29.32 Million42.97%
2006 -โ‚ฌ20.51 Million-23.03%
2005 -โ‚ฌ26.65 Million36.1%
2004 -โ‚ฌ19.58 Million172.57%
2003 -โ‚ฌ7.19 Million484.61%
2002 -โ‚ฌ1.23 Million
2000 -โ‚ฌ5.84 Million453.81%
1999 -โ‚ฌ1.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.43 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-โ‚ฌ19.01 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚ฌ4.72 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA